New therapies have been PBS listed for the treatment of genotype 1 chronic hepatitis C virus. AbbVie Australia today announced that Viekira Pak (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) and Viekira Pak-RBV (ombitasvir/paritaprevir/ritonavir tablets; dasabuvir tablets with ribavirin) will be listed on the PBS from 1st May 2016. The two therapies are approved for use
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.